How does the NFL stack up with health care?

ESPN, May 22, 2017
Michael McCann, citing Petrie-Flom's report

Sports Illustrated legal analyst Michael McCann joins OTL to discuss the NFL's health care for its players. Watch video here!

Read More

Angel investors are the first stop in a new era of drug development

Newsworks, May 11, 2017
Elana Gordon, quoting Rachel Sachs

From the article: So is this really the best way to develop new healthcare technologies and therapies? "So there are pros and there are cons," said Rachel Sachs, a law professor at Washington University in St. Louis who…

Read More

The Trump administration could bring down drug prices. But it would take guts

STAT News, May 15, 2017
Ed Silverman, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: “If Price and [President] Trump are interested in lower-priced drugs, they have access to a tool that enables them to do that,” explained Rachel Sachs, an associate professor at the Washington University School of Law who participated…

Read More

The White House budget director dropped a hint about how Trump could bring drug prices down

Washington Post, May 12, 2017
Carolyn Y. Johnson, quoting Rachel Sachs (Academic Fellow Alumna)

From the artcile: Trump has repeatedly said that drug prices are too high but has often suggested that increased bidding would be the best way to bring down prices. It has been unclear how that would work or whether Congress would support it. Mulvaney appeared…

Read More

New FDA Chief Scott Gottlieb: Medication Reformer or Big Pharma Shill?

The Fix, May 18, 2017
Paul Gaita, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: Gottlieb's position has earned cautious approval from medical industry observers like Washington University associate professor Rachel Sachs, who wrote, "As someone who understands the drug development process from all sides, [Gottlieb] will…

Read More

New York state wants its prescription drug money back—or else

USA Today, May 18, 2017
Julie Appleby, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: New York’s Medicaid program, for example, has seen its drug spending rise on average 8% each year over the past three years, after taking into account existing rebates. The program, which uses federal and state funds, serves more than…

Read More

Faculty Books in Brief—Spring 2017

Harvard Law Bulletin, May 18, 2017
Featuring book by I. Glenn Cohen (Faculty Director), Holly Fernandez Lynch (Executive Director), & Christopher T. Robertson (Academic Fellow Alumnus)

From the article: Cohen, faculty director of the Petrie-Flom Center; Lynch, the center’s executive director; and Robertson, a professor at University of Arizona’s College of Law, edit essays that focus on how health law and policy can—or should—use…

Read More

The NFL May Make A Smart Change To Its IR Rules

Deadspin, May 17, 2017
Dom Cosentino, citing Petrie-Flom's report

From the article: What the NFL could use is a short-term disabled list not unlike what exists in Major League Baseball. Right now, the NFL’s active and inactive lists function sort of like a DL, but with tighter roster restrictions. All teams have…

Read More

Babies from skin cells? New fertility technology raises ethical questions

The Current, May 19, 2017
Lara O'Brien and Karin Marley, interviewing I. Glenn Cohen (Faculty Director)

From the article: Women producing sperm. Or, for that matter, men producing eggs. Those could, in theory, be some of the results of a new reproductive technology that's looming on the horizon, according to Glenn Cohen. The…

Read More

Babies From Skin Cells? Prospect Is Unsettling to Some Experts

New York Times, May 16, 2017
Tamar Lewin, citing I. Glenn Cohen (Faculty Director)

From the article: Three prominent academics in medicine and law sounded an alarm about the possible consequences in a paper published this year. “I.V.G. may raise the specter of ‘embryo farming’ on a scale currently…

Read More

Harvard Study Looks At Ways NFL Can Bolster Player Health

Law360, May 16, 2017
Fola Akinnibi, quoting I. Glenn Cohen (Faculty Director) and citing Petrie-Flom's report

Law360, New York (May 16, 2017, 6:03 PM EDT) -- Harvard Law School published a report Monday exploring the National Football League’s health policies and practices, noting that the professional football league has done a good job with player safety and suggesting areas of improvement using…

Read More

New Report from the Law & Ethics Initiative of the Football Players Health Study: Harvard Report Compares NFL’s Health Policies and Practices to Those of Other Professional Sports Leagues

Petrie-Flom Center and Football Players Health Study at Harvard University, May 15, 2017

May 15, 2017 – While the NFL’s player health policies and practices are robust in some areas, there are opportunities for improvement in others, according to the findings of a newly released report by researchers at The…

Read More

Harvard’s Advice for NFL Player Health and Safety: The university’s independent study compared the NFL to five other North American sports leagues and made nine recommendations on how to help preserve the future of the game

MMQB, Sports Illustrated, May 15, 2017
Jenny Vrentas, quoting I. Glenn Cohen (Faculty Director) and citing Petrie-Flom's report

From MMQB:  Today’s 255-page report comes from Harvard Law School’s Petrie-Flom Center for health law policy, biotechnology and bioethics, and it compares the NFL’s policies and practices concerning player health against five other…

Read More

Harvard study suggests some NFL health and safety changes

Washington Post, May 15, 2017
Rick Maese, quoting I. Glenn Cohen (Faculty Director) and citing Petrie-Flom's report

From the Washington Post:  The physical demands are different. The types and severity of injuries are different. And the economics can vary wildly. But there are several common threads shared by professional sports leagues when it comes to health…

Read More

Harvard study: NFL should offer treatment for performance-enhancing drug users

Boston Globe, May 15, 2017
Travis Anderson, citing Petrie-Flom's report

From the Boston Globe:  The National Football League should consider providing treatment to any player caught using performance-enhancing drugs, according to a new Harvard University study. The recommendation was one…

Read More

Special Issue: Comparing Health Related Policies and Practices in Sports: The NFL and Other Professional Leagues

Journal of Sports Law and Entertainment, May 2017

The Journal of Sports and Entertainment Law at Harvard Law School published a Special Edition in May 2017, which prints in full the new report from the Petrie-Flom Center's Law & Ethics Initiative, part…

Read More

Sessions Suspends DOJ Forensic Science Commission (Audio)

Bloomberg Radio, April 11, 2017
David Sucherman, featuring Christopher Robertson (Academic Fellow Alumnus)

Christopher Robertson, professor of Law at the University of Arizona, and Brandon Garrett, professor at the University of Virginia School of Law, discuss U.S. attorney general Jeff Sessions’ announcement that he was terminating a Justice Department partnership with independent scientists to…

Read More

There’s a federal law to lower drug prices—and Louisiana may just use it

Ars Technica, May 4, 2017
Beth Mole, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Rachel Sachs, a law professor at Washington University in St Louis, told the KHN that this makes a good argument for summoning 28 U.S.C. § 1498. “The case is strong,” she said. If the law…

Read More

Louisiana proposes tapping a century-old patent law to cut hepatitis C drug prices

Kaiser Health News, May 2, 2017
Sarah Jane Tribble, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Rachel Sachs, an associate professor of law at Washington University in St. Louis who attended the recent Johns Hopkins meeting, said she believes “the case is strong” in invoking Section 1498, even though pharmaceutical companies may…

Read More

Petrie-Flom Welcomes New Executive Director!

Petrie-Flom Center, May 10, 2017

We are thrilled to announce that Carmel Shachar, JD, MPH (HLS ’10, HSPH ’10), will join the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School…

Read More